These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6832881)

  • 1. Therapeutic effect of rifampicin and isoniazid against Leishmania tropica major.
    Livshin R; El-On J; Weinrauch L; Greenblatt CL; Even-Paz Z
    Int J Dermatol; 1983; 22(1):61. PubMed ID: 6832881
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of rifampicin and isoniazid in cutaneous leishmaniasis.
    Livshin R; Weinrauch L; Even-Paz Z; el-On J
    Int J Dermatol; 1987; 26(1):55-9. PubMed ID: 3557792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis.
    Peters W; Lainson R; Shaw JJ; Robinson BL; Leão AF
    Lancet; 1981 May; 1(8230):1122-4. PubMed ID: 6112485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica.
    van der Meulen J; Mock B; Fekete E; Sarojini PA
    Lancet; 1981 Jul; 2(8239):197-8. PubMed ID: 6114258
    [No Abstract]   [Full Text] [Related]  

  • 5. Leishmaniasis: a case history and treatment failure with rifampin.
    White SW; Hendricks LD; Chulay JD
    Arch Dermatol; 1980 Jun; 116(6):620-1. PubMed ID: 7377797
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin treatment of cutaneous leishmaniasis.
    Even-Paz Z; Weinrauch L; Livshin R; El-On J; Greenblatt CL
    Int J Dermatol; 1982 Mar; 21(2):110-2. PubMed ID: 7040263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous leishmaniasis: an autochtonous case in Switzerland?].
    Mazzi R
    Dermatologica; 1976; 153(2):104-5. PubMed ID: 1001590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malaria tropica with a fixed combination of rifampicin, co-trimoxazole and isoniazid: a clinical study.
    Goerg H; Ochola SA; Goerg R
    Chemotherapy; 1999; 45(1):68-76. PubMed ID: 9876212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of diffuse cutaneous leishmaniasis: a report of two cases.
    Okelo GB; Sang D; Bhatt KM
    East Afr Med J; 1991 Jan; 68(1):67-8. PubMed ID: 1647944
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative studies on therapeutic effect of rifampicin and isoniazid on experimental mouse tuberculosis (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1978 Apr; 53(4):261-4. PubMed ID: 661058
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin, isoniazid (and streptomycin). (therapeutic results in primary complex pulmonary tuberculosis)].
    Fréour P; Bernadou M; Chomy P; Bollinelli J; Wanou JJ
    Rev Tuberc Pneumol (Paris); 1970; 34(5):698-706. PubMed ID: 5496791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals].
    Sodikov ES; Ismatullaev F
    Probl Tuberk; 1986; (6):50-3. PubMed ID: 3092209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermal leishmaniasis and rifampicin.
    Joshi RK; Nambiar PM
    Int J Dermatol; 1989 Nov; 28(9):612-4. PubMed ID: 2583909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrent mucosal leishmaniasis and pulmonary tuberculosis.
    Escobar MA; Saravia NG; Weigle KA
    Clin Infect Dis; 1996 Oct; 23(4):836-7. PubMed ID: 8909860
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
    McConkey B; Situnayake RD
    J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reply to "Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid"].
    Vidal García M; Samper Blasco S; Monforte Cirac ML
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):73-4. PubMed ID: 25212828
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampicin in combination with isoniazid in the treatment childhood tuberculosis.
    Rahaju NN; Sutoto ; Rahaju N; Budiman I; Sutejo
    Paediatr Indones; 1976; 16(11-12):544-53. PubMed ID: 1088375
    [No Abstract]   [Full Text] [Related]  

  • 20. Antileishmanial effects of clofazimine and other antimycobacterial agents.
    Evans AT; Croft SL; Peters W; Neal RA
    Ann Trop Med Parasitol; 1989 Oct; 83(5):447-54. PubMed ID: 2619361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.